Zidovudine: Anno 1995 View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1996

AUTHORS

Sven A. Danner

ABSTRACT

In early 1987 treatment of symptomatic HIV-infected patients was improved by the availability and licensing of the nucleoside analogue zidovudine (ZDV, AZT, Retrovir®) as the first anti-retroviral drug in most countries of the developed world. Although more compounds have become available since then, zidovudine remains a cornerstone of therapy for HIV infection. In most countries zidovudine monotherapy is still the first choice for HIV-infected patients who have become symptomatic or who have developed a CD4 lymphocyte count beneath 500/mm3. More... »

PAGES

225-243

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4757-9209-6_21

DOI

http://dx.doi.org/10.1007/978-1-4757-9209-6_21

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026361932

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8815688


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Microbial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Zidovudine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Danner", 
        "givenName": "Sven A.", 
        "id": "sg:person.01303761254.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303761254.85"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1996", 
    "datePublishedReg": "1996-01-01", 
    "description": "In early 1987 treatment of symptomatic HIV-infected patients was improved by the availability and licensing of the nucleoside analogue zidovudine (ZDV, AZT, Retrovir\u00ae) as the first anti-retroviral drug in most countries of the developed world. Although more compounds have become available since then, zidovudine remains a cornerstone of therapy for HIV infection. In most countries zidovudine monotherapy is still the first choice for HIV-infected patients who have become symptomatic or who have developed a CD4 lymphocyte count beneath 500/mm3.", 
    "editor": [
      {
        "familyName": "Mills", 
        "givenName": "John", 
        "type": "Person"
      }, 
      {
        "familyName": "Volberding", 
        "givenName": "Paul A.", 
        "type": "Person"
      }, 
      {
        "familyName": "Corey", 
        "givenName": "Lawrence", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4757-9209-6_21", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4757-9211-9", 
        "978-1-4757-9209-6"
      ], 
      "name": "Antiviral Chemotherapy 4", 
      "type": "Book"
    }, 
    "keywords": [
      "cornerstone of therapy", 
      "CD4 lymphocyte count", 
      "nucleoside analogue zidovudine", 
      "anti-retroviral drugs", 
      "zidovudine monotherapy", 
      "symptomatic HIV", 
      "lymphocyte count", 
      "HIV infection", 
      "first choice", 
      "HIV", 
      "patients", 
      "zidovudine", 
      "monotherapy", 
      "therapy", 
      "infection", 
      "drugs", 
      "treatment", 
      "most countries", 
      "count", 
      "mm3", 
      "more compounds", 
      "cornerstone", 
      "countries", 
      "choice", 
      "availability", 
      "compounds", 
      "licensing", 
      "world"
    ], 
    "name": "Zidovudine: Anno 1995", 
    "pagination": "225-243", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026361932"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4757-9209-6_21"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8815688"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4757-9209-6_21", 
      "https://app.dimensions.ai/details/publication/pub.1026361932"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_62.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4757-9209-6_21"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4757-9209-6_21'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4757-9209-6_21'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4757-9209-6_21'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4757-9209-6_21'


 

This table displays all metadata directly associated to this object as RDF triples.

125 TRIPLES      22 PREDICATES      61 URIs      53 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4757-9209-6_21 schema:about N1c67f66d319840aa80bf9612cbeb50bb
2 N4d78ec8b17a64d26a8c92e082a57b913
3 N578a6f258b064d45a8e8437cfe33e1b3
4 N7fb77078109044cdac8bfadd02b421d5
5 Ndb4bbceb6c79411babc923f6bd582208
6 Ne10840fb330c4da0931146ccb8d153b9
7 anzsrc-for:11
8 anzsrc-for:1103
9 anzsrc-for:1108
10 schema:author N09c6a423fb49495b8cd256d6f570d9f3
11 schema:datePublished 1996
12 schema:datePublishedReg 1996-01-01
13 schema:description In early 1987 treatment of symptomatic HIV-infected patients was improved by the availability and licensing of the nucleoside analogue zidovudine (ZDV, AZT, Retrovir®) as the first anti-retroviral drug in most countries of the developed world. Although more compounds have become available since then, zidovudine remains a cornerstone of therapy for HIV infection. In most countries zidovudine monotherapy is still the first choice for HIV-infected patients who have become symptomatic or who have developed a CD4 lymphocyte count beneath 500/mm3.
14 schema:editor N7cdedfc53ec341deb39120e410a86681
15 schema:genre chapter
16 schema:isAccessibleForFree false
17 schema:isPartOf Nac7bb413a8c04ee29ff364fa540c7046
18 schema:keywords CD4 lymphocyte count
19 HIV
20 HIV infection
21 anti-retroviral drugs
22 availability
23 choice
24 compounds
25 cornerstone
26 cornerstone of therapy
27 count
28 countries
29 drugs
30 first choice
31 infection
32 licensing
33 lymphocyte count
34 mm3
35 monotherapy
36 more compounds
37 most countries
38 nucleoside analogue zidovudine
39 patients
40 symptomatic HIV
41 therapy
42 treatment
43 world
44 zidovudine
45 zidovudine monotherapy
46 schema:name Zidovudine: Anno 1995
47 schema:pagination 225-243
48 schema:productId N137dc7461068478fba0ed8f47b5f9608
49 N65efd994ac1940fe83648d7b5f9198e2
50 N772d8966ba384661bae1dd22892a8f51
51 schema:publisher N7f3d5a28af3948eba0fba9d23827ff9b
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026361932
53 https://doi.org/10.1007/978-1-4757-9209-6_21
54 schema:sdDatePublished 2022-12-01T06:55
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher Nf7d01ec15ad4465f8ef5dec4d2cad92e
57 schema:url https://doi.org/10.1007/978-1-4757-9209-6_21
58 sgo:license sg:explorer/license/
59 sgo:sdDataset chapters
60 rdf:type schema:Chapter
61 N09c6a423fb49495b8cd256d6f570d9f3 rdf:first sg:person.01303761254.85
62 rdf:rest rdf:nil
63 N137dc7461068478fba0ed8f47b5f9608 schema:name dimensions_id
64 schema:value pub.1026361932
65 rdf:type schema:PropertyValue
66 N161baa04c7f24e55a6aff4bb9fbd9d06 rdf:first Nea2d99afe0204ea39f9e1d7e39af92a9
67 rdf:rest rdf:nil
68 N1c67f66d319840aa80bf9612cbeb50bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Animals
70 rdf:type schema:DefinedTerm
71 N4d78ec8b17a64d26a8c92e082a57b913 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Antiviral Agents
73 rdf:type schema:DefinedTerm
74 N578a6f258b064d45a8e8437cfe33e1b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Humans
76 rdf:type schema:DefinedTerm
77 N65efd994ac1940fe83648d7b5f9198e2 schema:name pubmed_id
78 schema:value 8815688
79 rdf:type schema:PropertyValue
80 N772d8966ba384661bae1dd22892a8f51 schema:name doi
81 schema:value 10.1007/978-1-4757-9209-6_21
82 rdf:type schema:PropertyValue
83 N7cdedfc53ec341deb39120e410a86681 rdf:first Nc0adc293cf2343f8a44cf5481418bb30
84 rdf:rest Nd78a9df3984a4150916ba8cbb1eb5929
85 N7f3d5a28af3948eba0fba9d23827ff9b schema:name Springer Nature
86 rdf:type schema:Organisation
87 N7fb77078109044cdac8bfadd02b421d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name HIV Infections
89 rdf:type schema:DefinedTerm
90 Nac7bb413a8c04ee29ff364fa540c7046 schema:isbn 978-1-4757-9209-6
91 978-1-4757-9211-9
92 schema:name Antiviral Chemotherapy 4
93 rdf:type schema:Book
94 Nc0adc293cf2343f8a44cf5481418bb30 schema:familyName Mills
95 schema:givenName John
96 rdf:type schema:Person
97 Ncadeaa79bf8f48bba0859ee2057fc520 schema:familyName Volberding
98 schema:givenName Paul A.
99 rdf:type schema:Person
100 Nd78a9df3984a4150916ba8cbb1eb5929 rdf:first Ncadeaa79bf8f48bba0859ee2057fc520
101 rdf:rest N161baa04c7f24e55a6aff4bb9fbd9d06
102 Ndb4bbceb6c79411babc923f6bd582208 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Zidovudine
104 rdf:type schema:DefinedTerm
105 Ne10840fb330c4da0931146ccb8d153b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Drug Resistance, Microbial
107 rdf:type schema:DefinedTerm
108 Nea2d99afe0204ea39f9e1d7e39af92a9 schema:familyName Corey
109 schema:givenName Lawrence
110 rdf:type schema:Person
111 Nf7d01ec15ad4465f8ef5dec4d2cad92e schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
114 schema:name Medical and Health Sciences
115 rdf:type schema:DefinedTerm
116 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
117 schema:name Clinical Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical Microbiology
121 rdf:type schema:DefinedTerm
122 sg:person.01303761254.85 schema:familyName Danner
123 schema:givenName Sven A.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303761254.85
125 rdf:type schema:Person
 




Preview window. Press ESC to close (or click here)


...